Azasetron
Azasetron is a pharmaceutical drug used primarily as an antiemetic to prevent nausea and vomiting caused by chemotherapy and radiotherapy. It belongs to the class of drugs known as 5-HT3 receptor antagonists, which work by blocking the action of serotonin at the 5-HT3 receptors.
Mechanism of Action[edit]
Azasetron works by inhibiting the action of serotonin at the 5-HT3 receptors located in the central nervous system and the gastrointestinal tract. By blocking these receptors, azasetron prevents the activation of the vomiting center in the brain, thereby reducing the sensation of nausea and the occurrence of vomiting.
Uses[edit]
Azasetron is primarily used in the management of chemotherapy-induced nausea and vomiting (CINV) and radiotherapy-induced nausea and vomiting (RINV). It is often administered prior to the initiation of chemotherapy or radiotherapy to prevent these side effects.
Administration[edit]
Azasetron can be administered orally or intravenously. The dosage and route of administration depend on the severity of the symptoms and the specific needs of the patient.
Side Effects[edit]
Common side effects of azasetron include:
Serious side effects are rare but may include:
Contraindications[edit]
Azasetron is contraindicated in patients with a known hypersensitivity to the drug or any of its components. Caution is advised in patients with a history of cardiovascular disease.
Related Drugs[edit]
Other drugs in the same class of 5-HT3 receptor antagonists include:
See Also[edit]
References[edit]
External Links[edit]
-
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian